Vimarsana
Biggest News Aggregation in the World

Igan Foundation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Igan Foundation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Igan Foundation Today - Breaking & Trending Today

Tillotama Shome Highlights The Tough Journey Of Indie Filmmakers Like Payal Kapadia - Vimarsana News

Tillotama Shome Highlights The Tough Journey Of Indie Filmmakers Like Payal Kapadia

New Delhi, May 26 (IANS) After Shweta Dhanwanthary spoke up about the travails of indie filmmakers who find it so hard to sell their storyboards in I

Source: menafn.com
Tillotama Shome highlights the tough journey of indie filmmakers like Payal Kapadia - Vimarsana News

Tillotama Shome highlights the tough journey of indie filmmakers like Payal Kapadia

After Shweta Dhanwanthary spoke up about the travails of indie filmmakers who find it so hard to sell their storyboards in India, OTT star Tillotama Shome took to Instagram with a heartfelt post to amplify the point.Both posts, which are ...

ALIGN Study: Atrasentan Shows Significant Benefit on Proteinuria in IgAN at 36 Weeks - Vimarsana News

ALIGN Study: Atrasentan Shows Significant Benefit on Proteinuria in IgAN at 36 Weeks

Atrasentan significantly reduces proteinuria in patients with IgA nephropathy, showing a 36.1% reduction compared to placebo at 36 weeks.

Luxbox selling a Palme d'Or hopeful at Cannes - Vimarsana News

Luxbox selling a Palme d'Or hopeful at Cannes

02/05/2024 - The French international sales agent will be pinning its hopes on Payal Kapadia’s competition title All We Imagine as Light and on Simon of the Mountain in the Critics’ Week

Calliditas IgAN treatment, Tarpeyo, given full FDA approval - Vimarsana News

Calliditas IgAN treatment, Tarpeyo, given full FDA approval

The US Food and Drink Administration (FDA) has approved Calliditas Therapeutics' Tarpeyo (budesonide) delayed-release capsules to reduce the loss of kidney function in adults with IgAN.